Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive phenylephrine for reducing transient tachypnea of the newborn after elective cesarean section under spinal anesthesia
ChiCTR2000032974Phase 4Recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phenylephrine in transient tachypnea of the newborn (TTN) (2 arms), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoint: Incidence of transient tachypnea of the newborn. Started May 2020; status: recruiting.
02
Drugs
phenylephrine
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on ChiCTR2000032974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032974.